Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Highly active anti-retroviral therapy (HAART) has changed the nature of HIV dementia: the degree of cognitive impairment is milder, the course may improve as well as worsen, and traditional biomarkers such as CSF viral load or levels of monocyte chemotactic protein 1 (MCP-1) are less likely to be associated with dementia.

Prediction and Diagnosis of HIV Dementia